¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"time factor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
oxygen gain factor
»ê¼ÒÀ̵æ°è¼ö
plasma coagulation factor
Ç÷ÀåÀÀ°íÀÎÀÚ
plasma thromboplastin factor
Ç÷À寮·Òº¸ÇÃ¶ó½ºÆ¾ÀÎÀÚ
platelet activating factor
Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ
platelet factor 3
Ç÷¼ÒÆÇÀÎÀÚ3
platelet factor 4
Ç÷¼ÒÆÇÀÎÀÚ4
platelet-derived growth factor
Ç÷¼ÒÆÇÀ¯·¡¼ºÀåÀÎÀÚ, Ç÷¼ÒÆÇ±â¿ø¼ºÀåÀÎÀÚ
precipitation factor
ħÀüÀÎÀÚ
predisposing factor
¼±Çà¿äÀÎ
prognostic factor
¿¹ÈÄÀÎÀÚ
prolactin inhibitory factor
ÇÁ·Î¶ôƾºÐºñ¾ïÁ¦ÀÎÀÚ
prolactin releasing factor
ÇÁ·Î¶ôƾºÐºñÀÎÀÚ
properdin factor B
ÇÁ·ÎÆä¸£µòBÀÎÀÚ
properdin factor D
ÇÁ·ÎÆä¸£µòDÀÎÀÚ
properdin factor E
ÇÁ·ÎÆä¸£µòEÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
mitogenic factor
ºÐ¿ÃËÁøÀÎÀÚ
myocardial depressant factor
½ÉÀå±Ù¾ïÁ¦ÀÎÀÚ
nerve growth factor
½Å°æ¼ºÀåÀÎÀÚ
neutron kerma factor
Áß¼ºÀÚÄ¿¸¶°è¼ö
neutrophil chemotactic factor
È£Áß±¸ÁÖ¼ºÀÎÀÚ, È£Áß±¸½ò¸²ÀÎÀÚ
obliquity factor
±â¿ï±â°è¼ö
occupancy factor
°ÅÁÖ°è¼ö
output factor
Ãâ·ÂÀÎÀÚ
oxygen gain factor
»ê¼ÒÀ̵æ°è¼ö
phantom scatter factor
ÆÒÅè»ê¶õ°è¼ö
plasma coagulation factor
Ç÷ÀåÀÀ°íÀÎÀÚ
plasma thromboplastin factor
Ç÷À寮·Òº¸ÇÃ¶ó½ºÆ¾ÀÎÀÚ
platelet activating factor
Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ
platelet-derived growth factor
Ç÷¼ÒÆÇÀ¯·¡¼ºÀåÀÎÀÚ, Ç÷¼ÒÆÇ±â¿ø¼ºÀåÀÎÀÚ
precipitation factor
ÃËÁø¿äÀÎ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
inhibition(-tory) factor, macrophage migration
´ë½Ä¼¼Æ÷ À¯ÁÖÀúÁöÀÎÀÚ
intensity factor
°µµÀÎÀÚ
plasma coagulation factor
Ç÷ÀåÀÀ°íÀÎÀÚ
plasma factor
Ç÷ÀåÀÎÀÚ(úìíìì×í), ÇöóÁÀÎÀÚ.
plasma factor
Ç÷ÀåÀÎÀÚ(úìíìì×í), ÇöóÁÀÎÀÚ(¡ì×í)
plasma thromboplastic factor
Ç÷À寮·Òº¸ÇÃ¶ó½ºÆ¾ÀÎÀÚ.
plasma thromboplastin factor
Ç÷À寮·Òº¸ÇÃ¶ó½ºÆ¾ÀÎÀÚ.
platelet activating factor
Ç÷¼ÒÆÇ Ȱ¼º ÀÎÀÚ
platelet factor 4
Ç÷¼ÒÆÇÀÎÀÚ(úìá³÷ùì×í) 4
platelet factor 4=PF4
Ç÷¼ÒÆÇÀÎÀÚ 4
platelet factor III
Ç÷¼ÒÆÇÁ¦»ïÀÎÀÚ.
platelet-activating factor (PAF)
Ç÷¼ÒÆÇ Ȱ¼ºÈÀÎÀÚ
platelet-activating factor (paf)
Ç÷¼ÒÆÇȰ¼ºÈÀÎÀÚ(úìá³÷ùüÀàõûùì×í)
platelet-derived growth factor
Ç÷¼ÒÆÇÀ¯·¡ Áõ½ÄÀÎÀÚ
platelet-derived growth factor(PDGF)
Ç÷¼ÒÆÇ À¯·¡ ¼ºÀå ÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
time gain compenstaion curve
½Ã°£ (ãÁÊà) °ÔÀÎ º¸»ó °î¼± (ÜÍßÁ ÍØàÊ)
time gain compenstaion curve
½Ã°£ °ÔÀÎ º¸»ó °î¼±
time gain control
½Ã°£ (ãÁÊà) °ÔÀÎ Á¶Àý (ðàï½)
time gain control
½Ã°£ °ÔÀÎ Á¶Àý
time interval
½Ã°£°£°Ý(ãÁÊàÊà̰).
time keeper
°è½Ã¿ø(ͪãÁê¬).
time lag
Áöü½Ã°£(òÀôòãÁÊà).
time motion curve
½Ã°£ ¿îµ¿ °î¼±
time of compounding
Á¶Á¦(ðàð¥)½Ã°£.
time of death
»ç¸Á½Ã°¢
time of flight (TOF)
È帧 ½Ã°£, À¯Ã¼ ¼Óµµ °Á¶
time of flight MR angiography
À¯Ã¼ ¼Óµµ °Á¶ ÀÚ±â°ø¸í Ç÷°üÁ¶¿µ¼ú
time of flight phenomenon
À¯Ã¼ ¼Óµµ °Á¶ Çö»ó
time of maximum flow
ÃÖ´ë ¿ä·ç±îÁöÀÇ ½Ã°£
time of relaxation
ÀÌ¿Ï(ì¬èÐ)½Ã°£.
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
12
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½